OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
08 jul 2012 - 22:42
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus gives update on Biolex Therapeutics
Bericht
OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO) provides an update on its partner Biolex Therapeutics (“Biolex”).
On 3 July 2012, Biolex filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Middle District of North Carolina.
We anticipate that a trustee will be appointed to sell the company’s assets. The proceeds of this transaction will be used to satisfy liabilities, which may include debts to creditors and investors.
Datum laatste update: 15 december 2025